The SOX10 transcription factor plays a role in the maintenance of progenitor cellmultipotency, lineage specification, cell differentiation, and is a major actor in the development of the neural crest. Ithas been implicated in Waardenburg syndrome (WS), a rare disorder characterized by the association of pigmentation abnormalities and deafness, but 
Introduction
SOX10 (MIM 602229) belongs to the SOX family of transcription factors, whose members are involved ina multitude of developmental and cellular processes. 1 First identified as a glial cell transcription factor, it wassoon revealed as a major playerin the development of neural crest (NC) cells. NC cells are a population of multipotent precursor cells that emerge at the borders of the neural tube,migrate extensively throughout the embryo, and differentiate into a variety of cell types includingskin pigment cells, and neurons and glia of the peripheral and enteric nervous systems. 2 SOX10 plays a role in the maintenance of progenitor multipotency, specification, and differentiation of numerous cell types through the regulation of several transcriptional targets. 1, [3] [4] [5] Its involvement in Waardenburg syndrome (WS) contributed significantly to the understanding of its function in NC in general and in the melanocytic and enteric lineages in particular. 6 WS is a clinically and genetically heterogeneous condition that manifests with sensorineural congenital deafness and abnormal pigmentation of the hair, skin, and iris. Four subtypes (WS1 to WS4 [MIM 193500, 193510, 148820, 277580] ) as well as neurological variant (PCWH, for Peripheral demyelinating neuropathy-Central dysmyelinating leukodystrophyWaardenburg syndrome-Hirschsprung disease [MIM 609136]) have beendescribed. 6 Since 1998, approximately 100 heterozygous point mutations or deletions of SOX10 have been reported, first in WS4 (WS with Hirschsprung disease/megacolon), 7 then in its neurological variant, 8 and finally in WS2 (WS without Hirschsprung disease) 9 (see also the WS gene mutation database at LOVD[Leiden Open Variation Database]). 6 To delineate the range of temporal bone abnormalities associated with impaired SOX10 function, we recently performed a study of MRI and/or CTscans of inner ears from 15 WS individuals. Incidentally, this study also revealed an unexpectedly high frequency of olfactory
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5 bulb agenesis (88% of the caseswho could be analyzed), 10 a finding that hadbeen described only once before in association with a SOX10 mutation. 11 Notably, one of the maleincluded in our radiological study hadpreviouslybeen reported as having anosmia and hypogonadism. 9 The association of anosmia and hypogonadotropic hypogonadism is known as Kallmann syndrome (KS[MIM 147950, 244200, 308700, 610628, 612370, 612702]) and explained by a pathological sequence in embryonic development. Premature interruption of the vomeronasaland terminal nerve fibers in the peripheral olfactory system have been shown to result in incomplete migration of the neuroendocrine GnRH (gonadotropin-releasing hormone)-cells along these nerves, precluding them from penetrating into the forebrain and reaching their final destination in the preoptic and hypothalamic region. 12 The prevalence of 608892, and 603961, respectively), but mutations in any of these genes have been identified inonly approximately 30% of KS individuals. 13 KS can beassociated witha variety of nonolfactory, non-reproductivesymptoms including deafness, but the association of KS withdeafness has so far received littlegeneticexplanation.
Here, we asked whether personsaffected byKScarrymutations in SOX10. We found a notable prevalence(about 38%) of SOX10 mutations in a groupof individualspresenting with the clinical association of KS and hearing impairment, thereby shedding new light on this clinical association. We showed that these mutations affect SOX10 function in vitro. Homozygous showing agenesis of the olfactory bulbs. Informed consent for genetic testing was obtained.Genomic DNA was extracted from peripheral blood leukocytes using standard protocols.These individuals did not carry mutations in the coding sequences of previously analyzed genes, specifically,KAL1, FGFR1, FGF8, PROKR2, andPROK2, all involved in KS.
Mutation screening
The coding exons of SOX10were analyzed by Sanger sequencing of the PCR products as previously described. 9 Mutations were named according to the international nomenclature based on RefSeqaccession number NM_006941.3 for the SOX10 cDNA. SOX10 deletions or rearrangements were sought using QMF-PCR with a method slightly modified from Bondurand et al., 2007. 9 The three coding exons were amplified in fiveamplicons sorted in two different reaction mixes. 
Animals and genotyping
The generation and genotyping of Sox10 lacZ mice (Sox10 tm1Weg ) have been described previously.
14 Experiments were performed in accordance with the ethical guidelines of the Institut National de la Santéet de la Recherche Médicale. Embryos at E12.5 and E14.5 were obtained from staged pregnancies, fixed in 4% paraformaldehyde (PFA) at 4°C, and frozen in OCT (Optimal Cutting Temperature)compound.Head sections (16 µm thick) were cutusinga Leica CM3050S cryostat. Alternatively, embryo heads were fixed in 1% PFA and 0.2% glutaraldehyde and used for X-Gal staining.
Immunostaining and X-Gal staining X-Gal staining followed standard procedures. Immunostaining ofmouse embryo sections wasperformed as described. 15 The primary antibodies used wereanti-SOX10 (N-20 or D-20)
(goat, 1/50 Santa Cruz), anti-TUJ1 (mouse, 1/1,000, Eurogentec), anti-BLBP/BFABP (rabbit, 1/5,000, kindly provided by T. Müller), 16 anti-P75 (rabbit, 1/500, Promega), anti-S100 (rabbit, 1/400, Dako Cytomation), anti-GnRH (rabbit, 1/500, Abcam), and anti-β-galactosidase(chicken, 1/500, Abcam).Secondary antibodies wereanti-goat-FITC, anti-rabbitCy3, anti-mouse-Cy3,anti-goat-AlexaFluor555, anti-rabbit-AlexaFluor488, anti-mouse- The number of GnRH-cells on the missing slides was scored as the mean of the previous and following ones. Preparations were mounted in Vectashield and examined using an Olympus SZH10 stereo-microscope coupled to the Visilog capture program or a Zeiss Axioplan 2 confocal microscope coupled to the Metamorph software package.
Human tissues
A human fetus was obtained from medically terminated pregnancyat 8 weeks of embryonic development, with parents' written informed consent. After fixation in a 4% formaldehyde solution,the head was embedded in paraffin.Serial sagittal sections (4 μm thick) were cut using a Microm HM340E microtomeand collected on Superfrost Plus slides (Thermo Scientific). Immunochemistry analysis was conducted as described 17 using the antibodies against SOX10, TUJ1, and S100 cited above. Due to the limited number of slides, double SOX10/S100 staining was performed on the nasal mesenchyme only.
Plasmids
The pECE-SOX10, pCMV-SOX10Myc, pECE-PAX3, pECE-EGR2, pGL3-MITFdel1718, and pGL3-Cx32 vectors have been describedpreviously. [18] [19] [20] The mutations identified were introduced within the pECE-SOX10 (in the case of c.2T>G mutation) or pCMV-SOX10Myc
constructs by site-directed mutagenesis using the QuikChange mutagenesis kit (Stratagene, Netherlands and the extracts were assayed for luciferase activity using the Luciferase Assay System (Promega, Madison, WI, USA) as described previously. 9, 19, 22 Production of SOX10 was assessed by immunoblot analysis using standard protocols. 23 Quantification was performed using GeneTools v3.05 software. Alternatively, cultures were fixed in 4% PFAfor 10 min at room temperatureand immunocytochemistry was performed as described above usingSOX10 N-20 andD-20 antibodies.
In silico analysis of the mutations
Mutationswere analyzed using software packages including Polyphen-2, SIFT, Alamut2. Clinical and molecular findings in persons carrying SOX10 mutations are summarized in Table 1 (cases A to F). All sixindividuals had anosmia as well asabsentor delayed spontaneous puberty. Two maleshad cryptorchidism, and one also had micropenis. One of them demonstrated early grayingof the hair.Interestingly, all but one were deaf.Pedigrees of the two familial cases are represented in Figure S1A . A sample from the clinically affected inserm-00836181, version 1 -20 Jun 2013
mother of case D (anosmia and deafness) (see Table 1 and Figure S1A ) wasobtained, and cosegregation of the mutation and the disease was confirmed.Parents could also be analyzed fortwo of the sporadic cases (caseB and E) and the mutation was proved to be de novo in both cases.
Five mutations result in impaired SOX10 function
In silico prediction suggested likely pathogenic consequences of all sixmutations. The splice site mutation c.698-1G>C was predicted to result incomplete loss of the last splice acceptor site using several programs, with consequences similar topreviously identified splice site mutations at the same location (c.698-2A>C, c.698-2A>T). 26, 27 The Polyphen2 and SIFT programsrespectively predicted a "likely damaging" and a "not tolerated" effect of the Figure 1E ). Synergistic activity was lost with PAX3,while it was retained with EGR2 on MPZ but not on GJB1( Figure 1E ).
The six mutations were also tested in a competition assay on the MITF promoter. They did not show any dominant negative effect at a ratio of 1:1 and 2:1 to the wild-type protein ( Figure   S1B ). Only at a ratio of 3:1 did the mutations(except p.Arg433Gln)induce a decrease of the luciferase induction.
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13 Functional analysis of SOX10 missense mutations previously identified in the context of WS allowed us to show that aminoacid substitutions in close contact with the main hydrophobic core of the HMG domain alter subcellular localization of the protein, leading to its accumulation in nuclear foci. 24 The hydrophobic core is composed of four highly conserved residues, two tryptophans and two phenylalanines, which are located at the intersection of the three α-helices that compose the HMG domain and maintain their structural shape. Together, these results stronglyindicatea pathogenic effect of five mutationsamong the six identified, all found in individuals presenting withthe clinical association of KS and deafness.
SOX10 mutations are rare in KS individuals without hearing impairment
We then aimedto determine whetherSOX10 is also involved in other clinical forms ofKS, and particularly in KSwithout deafness. We screened 86random KS individuals, including66
KScases without associated signs and 20 cases with non-olfactory, non-reproductiveadditional symptoms, for SOX10 point mutations ordeletions. We identifiedtwoadditional mutations Arg151is located close to the hydrophobic core of the protein ( Figure 2C , upper panel)
whereas the Met108 residuecontactsboth the hydrophobic core and the DNA target ( Figure   2C , lower panel), and is located in the bipartite NLS of SOX10. Its substitution couldthus affect SOX10 structure,binding to DNA and/or nuclear localization as the primary defect.
Immunocytochemistry experiments were performed to analyze the subcellular location of the mutant proteins. Both p.Met108Thr and p.Arg151Cys missense mutations resulted in partial cytoplasmic relocalization of SOX10 and subnuclear accumulation in foci ( Figure 2D ).
Luciferase assays confirmed theloss-of-function effect of these mutations on the MITF promoter, both alone and in the presence of the cofactor PAX3 ( Figure S1D ).
The seven likelypathogenic mutations found in this study are shownalong with the main functional domains of SOX10 ( Figure 2E ).Additional screening for mutations in the genes involved in KSor congenital non-syndromic forms of hypogonadotropic hypogonadism was performed in the individuals with a SOX10 mutation (A to H, Table 1 ) and only yieldeda SEMA3A heterozygous missense variant (p.Val435Ile) in caseE.This variant has been found at similar frequencies in KS individuals and control subjects, although it has been reported to have some deleterious functional consequences in vitro. 28 These results indicated that SOX10 mutations are rare in KS individuals without associated signs and confirmed that the clinical association of KS and hearing impairment is more specific. We then used a mouse model to explore the embryonic defect leading to KS as a result of impaired SOX10 function.
SOX10 is expressed in embryonic olfactory ensheathing cellsin mice and humans
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OECs, peculiar glial cells involved in the growth and guidance of the olfactory axons, have recently been shown to derive from NC in mouse and chick. SOX10 was used as a marker of NC-derived cells in these studies,and its pattern of expression indeed suggested that it is expressed by OECs. [29] [30] [31] As OECs are heterogeneous in the pattern of markers they express, 32 wefully characterizedthe SOX10 expression profile during development of the olfactory structures using antibodies directed against SOX10 and several markers of OECs.
In E12.5 mouse embryo, the olfactory, vomeronasal, and terminalnerve fibers can be seen in had formed from the rostral telencephalon,and a continuous outer layer of SOX10-expressing cells was observed, which corresponds to the ONL ( Figure 3D ). These cells were BLBPpositive and P75-negative, while only the outermost cellswere S100-positive ( Figure 3D and E).Apart from OECs, we observed some SOX10expression in the nasal glands ( Figure S2A and B). We also confirmed the presence of a few non-neuronal SOX10-expressing cells in the olfactory epithelium at this stage ( Figure S2C ), as previously reported.
29,31
Finaly, we studied SOX10 expression in the peripheral olfactory system of a human embryo at 8weeks of embryonic development (equivalent stage to mouse E14.5).Immunostaining experiments revealed that SOX10-expressing cells (nuclear, green) were located along the olfactory, vomeronasal, and terminal nerve trajectory (TUJ1 staining, red) in the nasal mesenchyme ( Figure 4A ), in the migratory mass, and in the olfactory bulb ( Figure 4B ).
Double staining of SOX10 with the OEC marker S100 along the olfactory nerves confirmed that SOX10-expressing cells are OECs ( Figure 4C ).
Together, these results confirmed SOX10 expression in OEC during early development of the peripheral olfactory system in miceand humans.
TheSox10 mutant mousehas olfactory ensheathing cell defects
We then used mice bearing a Sox10mutation (Sox10 The OEC defect impacts the development of olfactory, vomeronasal, and terminal nerves and the migration of neuroendocrine GnRH-cells
OECs ensheathe the olfactory, vomeronasal, and terminal nerve fibersand also contribute to axonal pathfinding, fasciculation, and defasciculation. 32 We thus looked at the trajectory of these nerve fibers in the Sox10 mutantembryos. TUJ1 staining on E14.5 heads showed that thenerves hadformed in mutant homozygotesdespitethealmost complete absence of OECs in the nasal mesenchyme ( Figure 6A ). However, axons wereabnormallyrouted; some of them did not target the olfactory bulb and instead contactedaxons from the other side, dorsally to the nasal septum (red arrowhead in Figure 6A ).Furthermore, as a result of the absence of OECs, axons were not ensheathed along their most ventraltrajectory, and their defasciculation could be observed near the nasal septum (red arrow on Figure 6A ; defasciculation is also visible on Figure 5D ).
Hypogonadism in KS results from the so-called olfacto-genital fetopathological sequence, whereby incomplete embryonic migration of the neuroendocrine GnRH-cells from the nose to the brain arises from the disruption of vomeronasal and terminal nerve fibers. 12 We therefore analyzed the migration of these cellsin the Sox10 mutantembryo. In E14. These results show that the Sox10 homozygous mutant mice, which have a complete lack of SOX10, also undergo a pathological sequence in embryonic development similar to that responsible for KS. The defects we observed in the Sox10 homozygous mutantmice are schematized in Figure 7 .
Discussion
KS is genetically heterogeneous, with various modes of transmission: autosomal recessive,
autosomal dominant with incomplete penetrance, X chromosome-linked, and oligogenic.
However, only 30% of cases havemutations in any of the nine genesidentifiedthusfar. 13, 28 Deafness is one of various non-olfactory, non-reproductive anomalies that are sometimesfound together with KS. 13 Its prevalence in KS individuals has been estimated at approximately 5%. 33 As our understanding of the molecular basis of KShas progressed, deafness has been reported in individuals with KAL1, FGFR1,FGF8or
CHD7mutations, but these cases remain relatively rare. [34] [35] [36] [37] [38] Taking into account the high prevalence of hearing impairment in the general population, the association of KS with deafness may sometimes be coincidental, as wasshown in a family where deafness cosegregated neither with KS nor with the FGF8 mutation. 39 Comparatively, the remarkably
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20 large penetrance of deafness in the KS individuals who carry mutations inSOX10 appears highly significant.
We characterized seven different SOX10 mutations in persons affected by KS. As in WS, themutations were found inthe heterozygous state together with a dominant mode of inheritance.Some phenotypic variation was observed. In family D, the mother, who also carries the mutation, suffered from deafness and anosmia but had a normal puberty and spontaneous pregnancy. Although mosaicism cannotbe excluded, this finding most likely refers to the usual variability of phenotypic expression that is frequentlyobserved in developmental disorders, and in particular in KS or SOX10-linked WS. Stochastic events and modifier genes are often proposedto explain at least part of the phenotypic variability.In this respect, the SEMA3A sequence variant that was found in caseE may influence the expression of the disease.
In the first part of our study, five mutations were found among 13individuals withthe clinical association of KS and deafness, corresponding to a SOX10 involvement of 38%. This rate may be slightly overestimated, because a few KS individuals with deafness and already known mutations in other genes had been excluded. However, to date SOX10 stands as the main gene involved in this specific clinical association.
The hearing loss was sensorineural, profound or total in most cases. The audiograms of cases D and E are shown in Figure S4 , illustrating a total loss of hearing on the two ears at all frequencies. In contrary, caseG showed a mild sensorineural hearing loss (30 dB at 1000 and 2000 Hz on the left ear, 40 dB from 250 to 1000 Hz on the right ear).A striking finding is the high proportion of femalesamong persons carryingSOX10 mutations in this series (4 femalesand 3 males), while KS has been estimated to be three tofive times more frequent in males than in females. 13 However, an approximately 1:1 sex ratio was also found in the group
of KSplusdeafness individuals (7 females out of 13 cases), an observation that needs to be confirmed by further studies.
Sevenof the 8 SOX10 sequence variations identified (four missense substitutions, one frameshift mutation, one splice site mutation, and onemutation of the initiation codon, schematically summarized in Figure 2E ) result, or are predicted to result, in an altered production or function of SOX10. We performed transactivation assays on two target genes of SOX10, namely MITF and MPZ. 19, 21 MITF was chosen due to its critical rolein melanocyte development, whereas MPZwas selected based on its known expression in OECs. 40 Our results do not support a deleterious effect of the p.Arg433Gln mutation. The other 7 mutations were found to alter subcellularlocalization and/or transactivation capacities, thus validating their deleterious effect. The fourmissense mutations located in the HMG domain showed a peculiar aspect of relocalization tonuclear bodies,whichwe had previously observed for aminoacid substitutions in close contact with the main hydrophobic core of the HMG domain. 24 Whether these foci are a cause or a consequence of the pathogenic effect is still unclear.
The c.2C>T substitution affects the SOX10initiation codon. However, immunostaining of cells transfected with cDNA carrying the mutation,using antibodies directed against the SOX10 aminoorcarboxy terminus, showed thatan in-frame protein is produced. The first inframe ATG codon corresponds to Met90 and, if used, would produce a protein conserving the HMG and transactivation domains, but lackingmost of the dimerization domain. 41 As Met90 is the only in-frame methionine more proximal to the two NLS, this hypothesisis consistent with our observation that the protein produced doesnot relocalize tothe cytoplasm. 42 Significantly, one of the KS individuals had early graying and deafness and therefore fulfilled the diagnosis criteria for type 2 WS, but no pigmentation defects were reported for the other cases. For some persons, clinical reevaluation was possible after the identification of the The involvement of SOX10 in mouse olfactory development was not suspected until recently, whenits expression was reported in OECs. [29] [30] [31] Here, we showed that SOX10 plays a major role in the development of these peculiar NC-derived glial cells. In Sox10-null mutant embryos, a large part of the peripheral embryonic olfactory system lacked OECs at the embryonic stages analyzed.
Our results showed that the OEC deficiency occurs prior to E12. The remaining OECs were located in the uppermostpart of the fronto-nasal mesenchyme, the migratory mass, and the ONL. They hadan abnormal expression profile and formed a discontinued and disorganized layer around the olfactory bulbs, indicating that SOX10 is alsoprobably involved in their identity and function at several locations. Several explanations can be proposed as to why some OECs persisted in the mutant mice. One possibility is that not all OECs are SOX10-dependent. Another hypothesis is a partial functional redundancy between SOX10 and another protein of the SOX family. SOX8, which together with SOX10
and SOX9 forms the E subgroup of SOX transcription factors, is a good candidate based on its expression in the ONL during embryogenesis and the described redundancy between SOXE subfamily members in other tissues. [43] [44] [45] Despite the markedly reduced number of OECs, the olfactory, vomeronasal, and terminal nerves had formed in the Sox10-null embryos, as had the olfactory bulbs. This finding may be surprising since OECs not only ensheathe and fasciculate the nerve fibers, but also extend processes ahead of the pioneer olfactory axons they ensheathe, suggesting that they orchestrate their growth and guidance. 32, 51 However, although the olfactory axons were formed and extended some processes toward the migratory mass and the olfactory bulb in the Sox10-null mutant embryos, we found that they were partially misrouted and defasciculated, thus confirming the role of OECs in these processes.
In the mouse, neuroendocrine GnRH-cells begin to leave the epithelium of the olfactory pit at approximatelyE11.5. They migrate in close association with growing fibers of the vomeronasal and terminal nerves, then penetrate into the rostral forebrain and continue their migration toward the hypothalamus along the terminal nerve or a branch of the vomeronasal nerve. 52 In E14.5 Sox10-null embryos, the latest embryonic stage we could examine, GnRHcells accumulatedoutside the brain, along the vomeronasal and terminal nerve pathway, in the regions devoid of OECs. Few GnRH-cells were seen in the forebrain of these mice, which inserm-00836181, version 1 -20 Jun 2013
24 could reflect an impaired or delayed migration.To the extent thatmice and humans are comparable, it remains to be determined whetherthe defective GnRH-cell migration in this particular genetic form of KS is primarily due to the absence of OECs on the vomeronasal and terminal nerve trajectory or to the defective structure of these nerves,as previously suggested in other genetic forms. 12 All the abnormalities we found in the Sox10mutant mouse were observed in homozygous embryos, and embryonic lethality of these mice precludes further testing of late olfactory developmentand fertility. In the normal ONL, OECs contribute to the defasciculation, sorting, and refasciculation of axonsand are therefore crucial to olfactory bulbglomeruli formation and the establishment of the olfactory topographic map. 32 They are also involved in the renewal of markedand have a high penetrancein humans, while they are much less evident in the Sox10homozygous mouse mutant.
10,53
Sox10is expressed in the melanocytic intermediate cells of the cochlear stria vascularis,which produce the endocochlear electric potential essential to the hearing process. 54 It is also widely expressed duringearly inner ear development before being restricted to the cochlear and vestibular ganglia and to supporting cells of the sensory epithelium. In addition to a specific role in glial development of the ganglia, SOX10 has been shown to promote the survival of cochlear progenitors during otocyst formation and differentiation of the organ of Corti. [53] [54] [55] In the Sox10 homozygous mutant mice, the structure and cellular organization of the organ of Corti appear normal, but the cochlear duct is shortened,with no apparentmalformation of the vestibule. 53 In humans, apart from the cochlear degeneration thought to take place in WS in 
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